Navigation Links
Codexis Appoints Singapore Laboratories Managing Director
Date:8/21/2007

REDWOOD CITY, Calif., Aug. 21 /PRNewswire/ -- Codexis, Inc., a private biotechnology company, today announced the appointment of Thomas Daussmann, Ph.D., to the new position of Vice President and Managing Director of Codexis Laboratories Singapore Pte. Ltd. CLS is the company's first facility in Asia. Dr. Daussmann will report to Alan Shaw, Ph.D., President and CEO.

"We are very pleased to name Dr. Daussmann to this important new position on the Codexis senior management team," Dr. Shaw said. "Thomas has built a strong track record of accomplishment as managing director of Codexis' Julich Chiral Solutions subsidiary, and he is a widely-respected scientist in the field of biocatalysis. He will play an equally critical role in building the company's Asian research and development presence."

Since 1999, Dr. Daussmann has served as managing director of Julich Chiral Solutions, (previously JFC-Julich Fine Chemicals), the Codexis enzyme and intermediates manufacturing facility in Germany. JFC was acquired by Codexis in 2005. Dr. Daussmann has authored or co-authored more than 25 scientific publication articles on biocatalytic manufacturing, and is named on numerous patent applications in the field. He received his bachelor's degree in biology from the University of Karlsruhe, his master's degree in biotechnology from the University of Kaiserslautern, and his Ph.D. degree in microbiology from the Research Centre in Julich (all in Germany). His doctoral study was conducted under the supervision of Professor Christian Wandrey, University of Bonn, a respected authority in biotechnology research.

Build-out has begun on the 20,000-square-foot research center in the Science Park III area of Singapore. It is scheduled to open this fall as an expansion of Codexis U.S. research and development operations. CLS will be able to house up to 80 research and operations personnel. Bio*One Capital Pte. Ltd. of Singapore led the Codexis Series D private financing ro
'/>"/>

SOURCE Codexis, Inc.
Copyright©2007 PR Newswire.All rights reserved

Page: 1 2

Related biology technology :

1. Sharon Ethanol appoints operations director
2. Kyron appoints former AMA chairman to board
3. Brady appoints GE efficiency expert as CTO
4. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
5. Johnson Controls appoints Roell to head EOC
6. SecurePipe appoints two senior execs
7. Milwaukees PointOne appoints new president and CEO
8. Third Wave appoints new chairman
9. Midwest Venture Summit disappoints; Cato grades Midwest governors
10. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors
11. TeraMEDICA Appoints Prekop as New President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... September 2, 2015 ... die Forschung und Entwicklung neuartiger Therapien für ... Darmerkrankungen und Reizdarm konzentriert, erhält vom US ... sein neues Medikament patentiert wird. Das Medikament ... bei Kindern verhindert und Entzündungen vorbeugt.   ...
(Date:9/1/2015)... 2015 Prostate cancer is the second ... men. One in seven men will be diagnosed ... are diagnosed annually. That said, not every diagnosis ... new technique, MRI Fusion Biopsy, to more accurately ... only the affected areas and monitoring areas ...
(Date:9/1/2015)... ... September 01, 2015 , ... VetStem Biopharma announces new ... facet joint problems can be caused by injuries and abnormalities of the cervical ... roots or of the spinal cord itself. This can manifest itself as any ...
(Date:9/1/2015)... , Sept. 1, 2015   Medfusion, ... facilitating the relationship between doctors and patients, today ... Durham, N.C. -based venture capital firms. ... and business association with Bull City Venture Partners ... , Medfusion Founder and Executive Chairman. "Both firms, ...
Breaking Biology Technology:Das Patent von Swecure zur Verhinderung von Allergien bei Kindern wird in den USA zugelassen 2September Is Prostate Cancer Awareness Month 2September Is Prostate Cancer Awareness Month 3September Is Prostate Cancer Awareness Month 4VetStem Biopharma Announces New Clinical Research Program for Equine Cervical Facet Joint Disease 2VetStem Biopharma Announces New Clinical Research Program for Equine Cervical Facet Joint Disease 3Medfusion Secures Funding to Continue Evolution and Advance Mobile Strategy 2Medfusion Secures Funding to Continue Evolution and Advance Mobile Strategy 3
... Inc. (NYSE: CRY ), and BioForm Medical, Inc. ... a CE Mark for the use of CryoLife,s,BioGlue Surgical ... a reconstructive plastic surgery procedure. The CE,Mark approval allows ... BioGlue will be distributed by CryoLife,s partner BioForm ...
... Environmental,Tectonics Corporation,s (Amex: ETC ) ("ETC" or ... of seven (7) BARA-MED(R) XD,Monoplace Hyperbaric Chambers to ... associated with Haelen Hyperbarics., ETC is delighted ... of,physician operated Hyperbaric Oxygen Therapy (HBOT) clinics. Haelen,Hyperbarics ...
... Also Completes FDA Submission for Removal of Clinical ... Genta,Incorporated (OTC Bulletin Board: GNTA) announced that the ... patents from the European,Patent Office for its pipeline ... to composition of matter for the tesetaxel drug,substance ...
Cached Biology Technology:CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery 2CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery 3CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery 4Environmental Tectonics Corporation's BioMedical Systems Division Awarded Contract for Multiple Monoplace Chambers 2Environmental Tectonics Corporation's BioMedical Systems Division Awarded Contract for Multiple Monoplace Chambers 3Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane 2Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane 3Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane 4
(Date:7/31/2015)... 2015 Den 10. internationale konference om Genomik ... 22. - 25. oktober i Shenzhen ... fødselsdag i år. Siden starten i 2006 er ICB ... ,omik,-feltet, og er en af de mest dynamiske, entusiastiske ... på nylige gennembrud og fremskridt inden for ,omik,-forskning, som ...
(Date:7/31/2015)... , 31 de julho de 2015 A ... www.icg-10.org ) será realizada pela BGI de 22-25 de outubro ... A conferência está celebrando seu 10 o. ... a ICG se tornou uma das reuniões mais influentes ... encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
(Date:7/31/2015)... 31 de julio de 2015 La 10 th ... celebrará por medio de BGI del 22 al 25 de octubre ... Este año, la conferencia celebra su décimo aniversario. ... convertido en una de las reuniones anuales más influyentes del ... las reuniones más dinámicas, entusiastas y mejores a nivel científico. ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... researchers say they have found ,missing heat, in the climate ... or stopped over the past decade. , Observational data ... cent of the planet with Polar regions and parts ... scientist at the University of York, and Robert Way, a ...
... (November 13, 2013) Scientists from the New York ... Medical Center (CUMC) have used stem cells created from ... diabetesWolfram syndrometo elucidate an important biochemical pathway for beta-cell ... colleagues were published today in Diabetes . ...
... provider of scientific, technical and medical information products and services, ... the first full open access journal within the Biochimica ... BBA Clinical will focus on translating molecular ... is a biomedical journal dedicated to publishing research on ...
Cached Biology News:'Missing heat' discovery prompts new estimate of global warming 2Human stem cells used to elucidate mechanisms of beta-cell failure in diabetes 2Human stem cells used to elucidate mechanisms of beta-cell failure in diabetes 3Elsevier's Biochimica et Biophysica Acta (BBA) journal series adds open access journal: BBA Clinical 2
... and ES1301 mutS are mismatch repair minus ... strains prevents repair of the newly synthesized ... efficiencies and making them helpful in such ... II Mutagenesis Systems. Both ES1301 and BMH ...
propidium iodide *1.0 mg/mL solution in water*...
Applications: (+) Immunocytochemistry and immunohistochemistry...
MOUSE ANTI RAT KAPPA/LAMBDA:HRP Immunogen: MARK-1: Rat kappa light chains (IR202 and IR968)MARL-15: Rat lambda light chains (RH58, IR31)...
Biology Products: